The predator becomes the prey: Regulating the ubiquitin system by ubiquitylation and degradation

Nature Reviews Molecular Cell Biology

Volumn 12, Issue 9, 2011, Pages 605-620

  Weissman, Allan M ^a   Shabek, Nitzan ^b   Ciechanover, Aaron ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; BRCA1 PROTEIN; CBL E3 PROTEIN; CELL CYCLE PROTEIN 20; CELL PROTEIN; CIAP1 PROTEIN; E6AP PROTEIN; FANCM PROTEIN; GP78 PROTEIN; HRD1 PROTEIN; MARCH7 PROTEIN; PROTEIN MDM2; RING1B PROTEIN; RNF168 PROTEIN; RNF8 PROTEIN; RO52 PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TEB4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBC6 PROTEIN; UBC7 PROTEIN; UBIQUITIN; UCHL1 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; USP25 PROTEIN; USP4 PROTEIN; USP6 PROTEIN; USP7 PROTEIN; UVOMORULIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ENDOPLASMIC RETICULUM; ENZYME REGULATION; EUKARYOTE; GENE CONTROL; HUMAN; NONHUMAN; PREDATOR; PREY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; UBIQUITINATION;

ANIMALS; FOOD CHAIN; HUMANS; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN; UBIQUITINATION; WIT AND HUMOR AS TOPIC;

EUKARYOTA;

EID: 80051978811     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3173     Document Type: Review

References (157)

1. Wilkinson, K. D. The discovery of ubiquitin-dependent proteolysis. Proc. Natl Acad. Sci. USA 102, 15280-15282 (2005). (Pubitemid 41528047)
2. Shabek, N., Iwai, K. & Ciechanover, A. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target. Biochem. Biophys. Res. Commun. 363, 425-431 (2007). (Pubitemid 47496121)
3. Hershko, A., Eytan, E., Ciechanover, A. & Haas, A. L. Immunochemical analysis of the turnover of ubiquitin-protein conjugates in intact cells. Relationship to the breakdown of abnormal proteins. J. Biol. Chem. 257, 13964-13970 (1982).
4. Haas, A. L. & Bright, P. M. The dynamics of ubiquitin pools within cultured human lung fibroblasts. J. Biol. Chem. 262, 345-351 (1987). (Pubitemid 17000027)
5. Patel, M. B. & Majetschak, M. Distribution and interrelationship of ubiquitin proteasome pathway component activities and ubiquitin pools in various porcine tissues. Physiol. Res. 56, 341-350 (2007).
6. Ciechanover, A., Elias, S., Heller, H., Ferber, S. & Hershko, A. Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes. J. Biol. Chem. 255, 7525-7528 (1980). (Pubitemid 11239454)
7. Vijay-Kumar, S., Bugg, C. E. & Cook, W. J. Structure of ubiquitin refined at 1.8 Å resolution. J. Mol. Biol. 194, 531-544 (1987).
8. Carlson, N. & Rechsteiner, M. Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J. Cell Biol. 104, 537-546 (1987). (Pubitemid 17024708)
9. Hiroi, Y. & Rechsteiner, M. Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett. 307, 156-161 (1992).
10. Leggett, D. S. et al. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 10, 495-507 (2002). (Pubitemid 35284170)
11. Shabek, N., Herman-Bachinsky, Y. & Ciechanover, A. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc. Natl Acad. Sci. USA 106, 11907-11912 (2009).
12. Verhoef, L. G. et al. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates. FASEB J. 23, 123-133 (2009).
13. Piotrowski, J. et al. Inhibition of the 26S proteasome by polyubiquitin chains synthesized to have defined lengths. J. Biol. Chem. 272, 23712-23721 (1997). (Pubitemid 27410947)
14. Park, Y., Yoon, S. K. & Yoon, J. B. The HECT domain of TRIP12 ubiquitinates substrates of the ubiquitin fusion degradation pathway. J. Biol. Chem. 284, 1540-1549 (2009).
15. Xia, Z. P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119 (2009).
16. Kimura, Y. et al. An inhibitor of a deubiquitinating enzyme regulates ubiquitin homeostasis. Cell 137, 549-559 (2009).
17. Anderson, C. et al. Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95, 724-731 (2005). (Pubitemid 41567165)
18. Hanna, J., Leggett, D. S. & Finley, D. Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol. Cell. Biol. 23, 9251-9261 (2003). (Pubitemid 37499812)
19. Verma, R. et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298, 611-615 (2002). (Pubitemid 35215317)
20. Lee, M. J., Lee, B. H., Hanna, J., King, R. W. & Finley, D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell Proteomics 10, R110.003871 (2011).
21. Hanna, J., Meides, A., Zhang, D. P. & Finley, D. A ubiquitin stress response induces altered proteasome composition. Cell 129, 747-759 (2007). (Pubitemid 46802382)
22. Hanna, J. et al. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127, 99-111 (2006). (Pubitemid 44466645)
23. Peth, A., Uchiki, T. & Goldberg, A. L. ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. Mol. Cell 40, 671-681 (2010).
24. Kumar, K. S., Spasser, L., Ohayon, S., Erlich, L. A. & Brik, A. Expeditious chemical synthesis of ubiquitinated peptides employing orthogonal protection and native chemical ligation. Bioconjug. Chem. 22, 137-143 (2011).
25. Ciechanover, A. & Ben-Saadon, R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 14, 103-106 (2004). (Pubitemid 38293450)
26. Papa, F. R. & Hochstrasser, M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366, 313-319 (1993). (Pubitemid 23349357)
27. Dupre, S. & Haguenauer-Tsapis, R. Deubiquitination step in the endocytic pathway of yeast plasma membrane proteins: crucial role of Doa4p ubiquitin isopeptidase. Mol. Cell. Biol. 21, 4482-4494 (2001). (Pubitemid 32588233)
28. Prakash, S., Inobe, T., Hatch, A. J. & Matouschek, A. Substrate selection by the proteasome during degradation of protein complexes. Nature Chem. Biol. 5, 29-36 (2009).
29. van Leeuwen, F. W., Hol, E. M. & Fischer, D. F. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system. J. Alzheimers Dis. 9, 319-325 (2006). (Pubitemid 44253326)
30. Lam, Y. A. et al. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl Acad. Sci. USA 97, 9902-9906 (2000).
31. Lorick, K. L. et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA 96, 11364-11369 (1999). (Pubitemid 29487386)
32. Ravid, T. & Hochstrasser, M. Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nature Cell Biol. 9, 422-427 (2007). (Pubitemid 46511075)
33. Dikic, I., Wakatsuki, S. & Walters, K. J. Ubiquitin-binding domains-from structures to functions. Nature Rev. Mol. Cell Biol. 10, 659-671 (2009).
34. Wade, M., Wang, Y. V. & Wahl, G. M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299-309 (2010).
35. Lee, J. T. & Gu, W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86-92 (2010).
36. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951 (2000). (Pubitemid 30180252)
37. Honda, R. & Yasuda, H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 19, 1473-1476 (2000). (Pubitemid 30171179)
38. Linke, K. et al. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15, 841-848 (2008). (Pubitemid 351524426)
39. Tanimura, S. et al. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447, 5-9 (1999). (Pubitemid 29134936)
40. Linares, L. K., Hengstermann, A., Ciechanover, A., Muller, S. & Scheffner, M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl Acad. Sci. USA 100, 12009-12014 (2003). (Pubitemid 37271506)
41. Okamoto, K., Taya, Y. & Nakagama, H. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. FEBS Lett. 583, 2710-2714 (2009).
42. Stad, R. et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2, 1029-1034 (2001). (Pubitemid 33130611)
43. Cummins, J. M. & Vogelstein, B. HAUSP is required for p53 destabilization. Cell Cycle 3, 689-692 (2004). (Pubitemid 40187888)
44. Li, M., Brooks, C. L., Kon, N. & Gu, W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886 (2004). (Pubitemid 38438482)
45. Meulmeester, E., Pereg, Y., Shiloh, Y. & Jochemsen, A. G. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166-1170 (2005). (Pubitemid 41365384)
46. Meulmeester, E. et al. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18, 565-576 (2005). (Pubitemid 40726233)
47. Acconcia, F., Sigismund, S. & Polo, S. Ubiquitin in trafficking: the network at work. Exp. Cell Res. 315, 1610-1618 (2009).
48. Rotin, D. & Kumar, S. Physiological functions of the HECT family of ubiquitin ligases. Nature Rev. Mol. Cell Biol. 10, 398-409 (2009).
49. Macias, M. J., Wiesner, S. & Sudol, M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513, 30-37 (2002). (Pubitemid 34242975)
50. Ryan, P. E., Davies, G. C., Nau, M. M. & Lipkowitz, S. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci. 31, 79-88 (2006). (Pubitemid 43221840)
51. Kales, S. C., Ryan, P. E., Nau, M. M. & Lipkowitz, S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 70, 4789-4794 (2010).
52. Davies, G. C. et al. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23, 7104-7115 (2004).
53. Ettenberg, S. A. et al. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 276, 27677-27684 (2001).
54. Magnifico, A. et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169-43177 (2003). (Pubitemid 37345936)
55. Yang, B. et al. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nature Immunol. 9, 1356-1363 (2008).
56. Gay, D. L., Ramon, H. & Oliver, P. M. Cbl-and Nedd4-family ubiquitin ligases: balancing tolerance and immunity. Immunol. Res. 42, 51-64 (2008).
57. Gallagher, E., Gao, M., Liu, Y. C. & Karin, M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl Acad. Sci. USA 103, 1717-1722 (2006). (Pubitemid 43228759)
58. Azakir, B. A. & Angers, A. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling. Cell. Signal. 21, 1326-1336 (2009).
59. Mouchantaf, R. et al. The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. J. Biol. Chem. 281, 38738-38747 (2006). (Pubitemid 46042001)
60. Tsai, Y. C. & Weissman, A. M. The unfolded protein response, degradation from endoplasmic reticulum and cancer. Genes Cancer 1, 764-778 (2010).
61. Fang, S. et al. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 98, 14422-14427 (2001). (Pubitemid 33121407)
62. Tsai, Y. C. et al. The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nature Med. 13, 1504-1509 (2007). (Pubitemid 350224250)
63. Morito, D. et al. Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRδF508. Mol. Biol. Cell 19, 1328-1336 (2008). (Pubitemid 351805088)
64. Ye, Y. et al. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl Acad. Sci. USA 102, 14132-14138 (2005). (Pubitemid 41429665)
65. Lee, J. N., Song, B., DeBose-Boyd, R. A. & Ye, J. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281, 39308-39315 (2006). (Pubitemid 46041890)
66. Chen, B. et al. The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc. Natl Acad. Sci. USA 103, 341-346 (2006). (Pubitemid 43122402)
67. Das, R. et al. Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol. Cell 34, 674-685 (2009).
68. Shmueli, A., Tsai, Y. C., Yang, M., Braun, M. A. & Weissman, A. M. Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 390, 758-762 (2009).
69. Ballar, P., Ors, A. U., Yang, H. & Fang, S. Differential regulation of CFTRΔF508 degradation by ubiquitin ligases gp78 and Hrd1. Int. J. Biochem. Cell Biol. 42, 167-173 (2010).
70. Gardner, R. G. et al. Endoplasmic reticulum degradation requires lumen to cytosol signaling. Transmembrane control of Hrd1p by Hrd3p. J. Cell Biol. 151, 69-82 (2000).
71. Iida, Y. et al. SEL1L protein critically determines the stability of the HRD1-SEL1L endoplasmic reticulum-associated degradation (ERAD) complex to optimize the degradation kinetics of ERAD substrates. J. Biol. Chem. 286, 16929-16939 (2011).
72. Carroll, S. M. & Hampton, R. Y. Usa1p is required for optimal function and regulation of the Hrd1p endoplasmic reticulum-associated degradation ubiquitin ligase. J. Biol. Chem. 285, 5146-5156 (2010).
73. Horn, S. C. et al. Usa1 functions as a scaffold of the HRD-ubiquitin ligase. Mol. Cell 36, 782-793 (2009).
74. Cao, R. et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298, 1039-1043 (2002). (Pubitemid 35247314)
75. Ben-Saadon, R., Zaaroor, D., Ziv, T. & Ciechanover, A. The polycomb protein RING1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol. Cell 24, 701-711 (2006). (Pubitemid 44839211)
76. Kim, H. T., Kim, K. P., Uchiki, T., Gygi, S. P. & Goldberg, A. L. S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains. EMBO J. 28, 1867-1877 (2009).
77. Zaaroor-Regev, D. et al. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proc. Natl Acad. Sci. USA 107, 6788-6793 (2010).
78. Bernassola, F., Ciechanover, A. & Melino, G. The ubiquitin proteasome system and its involvement in cell death pathways. Cell Death Differ. 17, 1-3 (2010).
79. Vucic, D., Dixit, V. M. & Wertz, I. E. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nature Rev. Mol. Cell Biol. 12, 439-452 (2011).
80. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M. & Ashwell, J. D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877 (2000). (Pubitemid 30257739)
81. Ditzel, M. et al. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nature Cell Biol. 5, 467-473 (2003). (Pubitemid 36592271)
82. Ryoo, H. D., Bergmann, A., Gonen, H., Ciechanover, A. & Steller, H. Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1. Nature Cell Biol. 4, 432-438 (2002). (Pubitemid 34746161)
83. Herman-Bachinsky, Y., Ryoo, H. D., Ciechanover, A. & Gonen, H. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death Differ. 14, 861-871 (2007). (Pubitemid 46444523)
84. Steller, H. Regulation of apoptosis in Drosophila. Cell Death Differ. 15, 1132-1138 (2008). (Pubitemid 351850965)
85. Wing, J. P. et al. Drosophila Morgue is an F box/ubiquitin conjugase domain protein important for grim-reaper mediated apoptosis. Nature Cell Biol. 4, 451-456 (2002). (Pubitemid 34746164)
86. Fu, J., Jin, Y. & Arend, L. J. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. J. Biol. Chem. 278, 52660-52672 (2003). (Pubitemid 38035863)
87. Silke, J., Kratina, T., Ekert, P. G., Pakusch, M. & Vaux, D. L. Unlike Diablo/Smac, Grim promotes global ubiquitination and specific degradation of X chromosome-linked inhibitor of apoptosis (XIAP) and neither cause apoptosis. J. Biol. Chem. 279, 4313-4321 (2004). (Pubitemid 38199019)
88. Garrison, J. B. et al. ARTS and Siah collaborate in a pathway for XIAP degradation. Mol. Cell 41, 107-116 (2011).
89. Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513 (2009).
90. Cuervo, A. M., Palmer, A., Rivett, A. J. & Knecht, E. Degradation of proteasomes by lysosomes in rat liver. Eur. J. Biochem. 227, 792-800 (1995).
91. Isasa, M. et al. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Mol. Cell 38, 733-745 (2010).
92. Panasenko, O. O. & Collart, M. A. Not4 E3 ligase contributes to proteasome assembly and functional integrity in part through Ecm29. Mol. Cell. Biol. 31, 1610-1623 (2011).
93. Holic, R. et al. Cks1 activates transcription by binding to the ubiquitylated proteasome. Mol. Cell. Biol. 30, 3894-3901 (2010).
94. Tai, H. C., Besche, H., Goldberg, A. L. & Schuman, E. M. Characterization of the brain 26S proteasome and its interacting proteins. Front. Mol. Neurosci. 3, 12 (2010).
95. Peth, A., Besche, H. C. & Goldberg, A. L. Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol. Cell 36, 794-804 (2009).
96. Bech-Otschir, D. et al. Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome. Nature Struct. Mol. Biol. 16, 219-225 (2009).
97. Sun, X. M. et al. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell 14, 81-93 (2004).
98. Wang, X. H. et al. Caspase-3 cleaves specific 19S proteasome subunits in skeletal muscle stimulating proteasome activity. J. Biol. Chem. 285, 21249-21257 (2010).
99. Wang, X., Yen, J., Kaiser, P. & Huang, L. Regulation of the 26S proteasome complex during oxidative stress. Sci. Signal. 3, ra88 (2010).
100. Medicherla, B. & Goldberg, A. L. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J. Cell Biol. 182, 663-673 (2008).
101. Bajorek, M., Finley, D. & Glickman, M. H. Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr. Biol. 13, 1140-1144 (2003). (Pubitemid 36815263)
102. Peters, J. M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nature Rev. Mol. Cell Biol. 7, 644-656 (2006).
103. Manchado, E., Eguren, M. & Malumbres, M. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and-independent functions. Biochem. Soc. Trans. 38, 65-71 (2010).
104. Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol. 1, 193-199 (1999). (Pubitemid 129500937)
105. Sutterluty, H. et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol. 1, 207-214 (1999). (Pubitemid 129500939)
106. Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H. & Zhang, H. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661-664 (1999).
107. Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. & Pagano, M. Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase. Nature 428, 190-193 (2004). (Pubitemid 38374316)
108. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198 (2004). (Pubitemid 38374317)
109. Yamanaka, A. et al. Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome. Mol. Biol. Cell 11, 2821-2831 (2000). (Pubitemid 30645045)
110. Listovsky, T. et al. Mammalian Cdh1/Fzr mediates its own degradation. EMBO J. 23, 1619-1626 (2004). (Pubitemid 38579522)
111. Benmaamar, R. & Pagano, M. Involvement of the SCF complex in the control of Cdh1 degradation in S-phase. Cell Cycle 4, 1230-1232 (2005). (Pubitemid 41365394)
112. Hsu, J. Y., Reimann, J. D., Sorensen, C. S., Lukas, J. & Jackson, P. K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1. Nature Cell Biol. 4, 358-366 (2002). (Pubitemid 34521031)
113. Reimann, J. D., Gardner, B. E., Margottin-Goguet, F. & Jackson, P. K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278-3285 (2001). (Pubitemid 34013499)
114. Reimann, J. D. et al. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645-655 (2001). (Pubitemid 32524117)
115. Di Fiore, B. & Pines, J. Defining the role of Emi1 in the DNA replication-segregation cycle. Chromosoma 117, 333-338 (2008).
116. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799-812 (2003). (Pubitemid 36676033)
117. Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCFβTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813-826 (2003). (Pubitemid 36676034)
118. Moshe, Y., Boulaire, J., Pagano, M. & Hershko, A. Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome. Proc. Natl Acad. Sci. USA 101, 7937-7942 (2004). (Pubitemid 38698032)
119. Hansen, D. V., Loktev, A. V., Ban, K. H. & Jackson, P. K. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFβTrCP-dependent destruction of the APC inhibitor Emi1. Mol. Biol. Cell 15, 5623-5634 (2004). (Pubitemid 39564753)
120. Xu, P. et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133-145 (2009).
121. Matsumoto, M. L. et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 39, 477-484 (2010).
122. Saeki, Y. et al. Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J. 28, 359-371 (2009).
123. Carvalho, A. F. et al. Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J. Biol. Chem. 282, 31267-31272 (2007). (Pubitemid 350044882)
124. Cadwell, K. & Coscoy, L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309, 127-130 (2005). (Pubitemid 40934990)
125. Ishikura, S., Weissman, A. M. & Bonifacino, J. S. Serine residues in the cytosolic tail of the T-cell antigen receptor α-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J. Biol. Chem. 285, 23916-23924 (2010).
126. Wang, X. et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177, 613-624 (2007). (Pubitemid 46799833)
127. Williams, C., van den Berg, M., Sprenger, R. R. & Distel, B. A conserved cysteine is essential for Pex4p-dependent ubiquitination of the peroxisomal import receptor Pex5p. J. Biol. Chem. 282, 22534-22543 (2007). (Pubitemid 47267315)
128. Tait, S. W. et al. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 179, 1453-1466 (2007).
129. Shimizu, Y., Okuda-Shimizu, Y. & Hendershot, L. M. Ubiquitylation of an ERAD substrate occurs on multiple types of amino acids. Mol. Cell 40, 917-926 (2010).
130. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993). (Pubitemid 23335075)
131. Nuber, U., Schwarz, S. E. & Scheffner, M. The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur. J. Biochem. 254, 643-649 (1998).
132. Hassink, G. et al. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem. J. 388, 647-655 (2005). (Pubitemid 40839943)
133. Wang, L. et al. Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II. Hepatology 48, 1558-1569 (2008).
134. Zavacki, A. M. et al. The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase. Mol. Cell. Biol. 29, 5339-5347 (2009).
135. Zhou, P. & Howley, P. M. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol. Cell 2, 571-580 (1998). (Pubitemid 128379083)
136. Li, X., Yang, Y. & Ashwell, J. D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345-347 (2002).
137. Wu, W. et al. HERC2 is an E3 ligase that targets BRCA1 for degradation. Cancer Res. 70, 6384-6392 (2010).
138. Kee, Y., Kim, J. M. & D'Andrea, A. D. Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev. 23, 555-560 (2009).
139. Lilley, C. E. et al. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J. 29, 943-955 (2010).
140. Nathan, J. A. et al. The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic 9, 1130-1145 (2008). (Pubitemid 351916888)
141. Wada, K. & Kamitani, T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 339, 415-421 (2006). (Pubitemid 41697564)
142. Wada, K., Niida, M., Tanaka, M. & Kamitani, T. Ro52-mediated monoubiquitination of IKKβ down-regulates NF-κB signalling. J. Biochem. 146, 821-832 (2009).
143. Shen, C. et al. Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. J. Biol. Chem. 280, 35967-35973 (2005). (Pubitemid 41633865)
144. Meray, R. K. & Lansbury, P. T. J. Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem. 282, 10567-10575 (2007). (Pubitemid 47093406)
145. Todi, S. V. et al. Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J. 28, 372-382 (2009).
146. Todi, S. V. et al. Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117. J. Biol. Chem. 285, 39303-39313 (2010).
147. Ying, Z. et al. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum. Mol. Genet. 18, 4268-4281 (2009).
148. Wada, K. & Kamitani, T. UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. Biochem. Biophys. Res. Commun. 342, 253-258 (2006). (Pubitemid 43247384)
149. Boutell, C., Canning, M., Orr, A. & Everett, R. D. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79, 12342-12354 (2005). (Pubitemid 41346096)
150. Lee, H. J., Kim, M. S., Kim, Y. K., Oh, Y. K. & Baek, K. H. HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized. FEBS Lett. 579, 4867-4872 (2005).
151. Denuc, A., Bosch-Comas, A., Gonzalez-Duarte, R. & Marfany, G. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS ONE 4, e5571 (2009).
152. Bazirgan, O. A. & Hampton, R. Y. Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo. J. Biol. Chem. 283, 12797-12810 (2008).
153. Kostova, Z., Mariano, J., Scholz, S., Koenig, C. & Weissman, A. M. A Ubc7p-binding domain in Cue1p activates ER-associated protein degradation. J. Cell Sci. 122, 1374-1381 (2009).
154. Kreft, S. G. & Hochstrasser, M. An unusual transmembrane helix in the Doa10 ERAD ubiquitin ligase modulates degradation of its cognate E2. J. Biol. Chem. 286, 20163-20174 (2011).
155. Ho, C. W., Chen, H. T. & Hwang, J. UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae. J. Biol. Chem. 286, 21826-21834 (2011).
156. Pichler, A. et al. SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nature Struct. Mol. Biol. 12, 264-269 (2005). (Pubitemid 43079369)
157. Duda, D. M. et al. Structural regulation of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 21, 257-264 (2011).